Peptide Therapeutics Foundation

EIN: 263728931 501(c)(3) Medical Research

San Diego, CA

Total Revenue
$226,103
Total Expenses
$156,402
Total Assets
$404,964
Net Assets
$404,964
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2008
Legal Domicile
CA
Principal Officer
Adrienne Day PHD
Phone
8586571511
Tax Period
2025-01-01 to 2025-12-31

Peptide Therapeutics Foundation, founded in 2008, is a small nonprofit in the Medical Research sector that reported $226K in total revenue in fiscal year 2025. The organization ran a surplus of $70K, a strong 31% operating margin.

Mission

The mission of Peptide Therapeutics Foundation is to provide and promote public and charitable educational and information programs, materials, research and discussion in the the medical scientific field of peptide science and technology

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $99,793
Program Service Revenue $110,091
Investment Income $16,219
Other Revenue $0
TOTAL REVENUE $226,103

Expense Breakdown

Grants Paid $0
Salaries & Benefits $0
Fundraising Expenses $0
Program Expenses $129,567
Other Expenses $156,402
TOTAL EXPENSES $156,402

Year-over-Year Comparison

2025 2024 Change
Revenue $226,103 N/A N/A
Expenses $156,402 N/A N/A
Net Income $69,701 N/A N/A
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
5
Independent Members
5
Employees
N/A
Volunteers
5

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
4
$0
Total Directors
0
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
Phil Dawson PhD Chairman of Board 1.00
Officer
$0 $0 $0
Adam Mezo PhD President 1.00
Officer
$0 $0 $0
Bryan Fuchs PhD Secretary 1.00
Officer
$0 $0 $0
Adrienne Day PhD Treasurer and Board Administrator 1.00
Officer
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $226,103 $156,402 $404,964 $69,701
Explore More Nonprofits
→Top 100 Nonprofits in California →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare Peptide Therapeutics Foundation with other nonprofits in California and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.